Navigation

    Forum

    • Register
    • Login
    • Search
    • Categories
    • Recent
    • Popular
    • Users
    • Groups

    Exploratory endpoints

    PAAB Q&A
    2
    2
    471
    Loading More Posts
    • Oldest to Newest
    • Newest to Oldest
    • Most Votes
    Reply
    • Reply as topic
    Log in to reply
    This topic has been deleted. Only users with topic management privileges can see it.
    • U
      Username last edited by

      Is it permissible to include mention of exploratory endpoints in a description of a study design, if the endpoint is not included in the PM? No results would be presented in the piece. Does the design of the study affect the permissibility (open-label vs. double-blind, single-arm vs. placebo-controlled)?

      Jennifer Carroll 1 Reply Last reply Reply Quote 0
      • Jennifer Carroll
        Jennifer Carroll @Username last edited by

        Hello @username
        If the endpoint in the study is one that would not be acceptable for presentation within the piece (such as an exploratory endpoint), it would not be acceptable to mention, even in a claim neutral manner, regardless of whether the study was open-label, double blinded, single-arm, or placebo-controlled.

        1 Reply Last reply Reply Quote 0
        • First post
          Last post